Nova Ltd vs Koninklijke Philips NV — how do they compare? Nova Ltd trades at $353 (market cap $11.28B), while Koninklijke Philips NV trades at $24.24 (market cap $23.52B). The key difference: Koninklijke Philips NV is far larger — about 2.1× Nova Ltd's market cap, and Koninklijke Philips NV pays a 4.17% dividend while Nova Ltd pays none. Which is the better fit depends on your goals — on Pluang, investors hold Nova Ltd for 4 Days and Koninklijke Philips NV for 84 Days on average.
| NVMI | PHG | |
|---|---|---|
Market Cap | $11.28B | $23.52B |
Volume | 394,997 | 1,635,069 |
Sector | Technology | Health |
52-Week High | $605.65 | $32.91 |
52-Week Low | $275.78 | $23.81 |
Typical Hold Time | 4 Days | 84 Days |
Enterprise Value | $11.06B | $29.87B |
Dividend Yield | — | 4.17% |
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
PHG trades at $24.30, up 0.87% with a bearish technical signal despite recent earnings beats. The company shows improving fundamentals with net income turning positive to $895M in 2025 after previous losses, supported by strong cash flow generation. Recent news highlights product innovations including new CT systems and AI healthcare advancements, while institutional ownership shows mixed activity.
The outlook remains cautious with analyst consensus at Hold (63.64%) despite positive earnings momentum. Key risks include cybersecurity threats and competitive pressures in health technology. The stock presents a recovery opportunity but requires monitoring of execution risks and market sentiment shifts.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Nova provides metrology solutions for semiconductor manufacturing. Its systems measure material and process characteristics to help chipmakers control production across advanced nodes and packaging.
Read more on NVMI →Philips is a diversified global healthcare company operating in three segments: diagnosis and treatment, connected care, and personal health. About 50% of the company's revenue comes from the diagnosis and treatment segment, which features imaging systems, ultrasound equipment, image-guided therapy solutions and healthcare informatics. The connected care segment (27% of revenue) encompasses monitoring and analytics systems for hospitals and sleep and respiratory care devices, whereas the personal health business (remainder of revenue) includes electric toothbrushes and men's grooming and personal-care products. In 2021, Philips generated EUR 17.2 billion in sales and had 80,000 employees in over 100 countries.
Read more on PHG →